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INTRODUCTION
Drug addiction is a serious public health
problem that consists of a compulsive
drive to take drugs despite repeated severe
adverse consequences (1). Factors that
influence the development and mainte-
nance of addiction include access to drugs,
social environment, genetic predisposition,
and psychiatric comorbidities (2). Even in
the absence of specific psychiatric diag-
noses, certain psychological vulnerabili-
ties may serve as substrates compound-
ing the initiation of drug use and the
development of substance use disorders.
For example, individual who are sensation-
seekers, impulsive, or behavioral disinhib-
ited appear more prone to develop addic-
tion to both licit and illicit substances (3–
6). In this context, it is to be noted that not
all individuals who try these drugs become
addicted as about only 20% of people who
have tried drugs become addicts (7). It is
also worth mentioning that repeated expo-
sure to moderate to large doses of some
of these illicit drugs may be associated
with well-known neuropathological con-
sequences (8, 9) that might not be either
necessary or sufficient for the development
and the maintenance of addicted states.
The accumulated evidence supports the
view that a large number of substance
users suffer from significant neuropsy-
chological impairments (10). Neuroimag-
ing studies in drug-dependent individu-
als have also documented significant func-
tional and structural alterations in several
brain regions (1). These regions include
mesocortical, mesolimbic, and mesostri-
atal brain regions that are known to be
impacted by administration of licit and
illicit drugs in both clinical and preclinical
studies (2). In what follows, we discuss the
potential impact of illicit drugs on these
brain regions and the associated cogni-
tive consequences of these drugs. We then
suggest that these cognitive consequences
play primary roles in the maintenance of
addiction across several classes of abused
substances.
PRE-EXISTING COGNITIVE DEFICITS IN
SUBSTANCE USE DISORDERS
Before elaborating the idea of drug-
induced cognitive changes in patients
addicted to illicit drugs, it is important to
briefly discuss the influence of potential
premorbid deficits on the cognitive per-
formance of some drugs abusers (11). For
example, Ersche et al. (12) suggested that
cognitive dysfunctions and impulsive per-
sonality traits are endophenotypes for drug
dependence. Drug-dependent individuals
were significantly impaired on all the tests
used in their study and some of these cog-
nitive deficits were also found to exist in
first-degree relatives in the absence of drug
abuse (12). Levels of impulsivity were also
higher in drug-dependent individuals than
in their siblings, indicating that chronic
drug abuse further increases both anxiety
and impulsive traits. Smith et al. (13) also
reported that impairments in hemispheric
lateralization during task performance
were apparent in both drug-using subjects
and their control siblings, with the siblings
decreasing but the drug users increasing
activity in relevant brain regions.
ADDICTION AS A HYPERCONNECTION
SYNDROME
The prefrontal cortex (PFC) and the stria-
tum participate in integrated functions
that are modulated by glutamate (12)
and dopamine (DA) (14). These functions
include decision making (15), salience
attribution and goal-directed behaviors
(16), and inhibitory control of behaviors
(17) that are subsumed by specific cor-
tical subregions. Under normal circum-
stances, organisms consider many salient
behaviors but must choose to perform
one or the other by performing specific
very fast calculations of cost/benefit ratios
(18). These activities, including selection
of actions based on their valuation, are
thought to depend on the PFC (18). Nev-
ertheless, successful completion of goal-
directed behaviors such as searching for
food or drugs must require more com-
plex and extended sequences of actions
that must be maintained despite obsta-
cles and distractions. In people addicted
to drugs, there seems to be a narrow-
ing of goal selection, with substances of
abuse becoming more salient than other
choices (19). This narrowing might be
dependent on abnormal dynamics of DA
release in the PFC with subsequent effects
on corticostriatal glutamate projections to
the dorsal striatum that might be inti-
mately involved in the compulsive man-
ifestations of drug-taking behaviors (20,
21). In other words, although the ini-
tial effects of drugs might be to enhance
DA release in various brain regions (22),
repeated exposure to these drugs might
lead to subsequent weaker DA release,
tolerance to drug effects, followed by
increased drug taking to recalibrate the
functional interactions of the corticostri-
atal loops.
Pathological changes in the
orbitofrontal cortex (OFC) might also
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be involved in the manifestation of
addiction-related behaviors because it is
relevant to outcomes related to primary
reinforcers (23). OFC neurons encode
details concerning the sensory properties
of rewards, the size, and timing of past or
future rewards (23). Impairments in the
OFC result in compulsive behaviors and
impulsivity (24). A potential role of the
OFC in the maintenance of addiction is
supported by the observation of loss of
prefrontal gray matter in individuals with
a long history of drug abuse (25). This dis-
cussion is also supported by the report of
decreased striatal D2R availability, known
to be located on the indirect striatal pro-
jecting neurons, in the striatum of cocaine
and methamphetamine addicts (26, 27). It
is thus not farfetched to suggest that unop-
posed actions of D1-like DA receptors
through the direct basal ganglia pathway
may promote states of hyperconnections
within basal ganglionic/cortical functional
and structural loops. These hypothesized
hyperconnections might be responsible





Impaired self-control plays a fundamental
role in drug-taking behaviors in addictive
states (11). Impulsivity is often referred
by the term “disinhibition,” referring to
the idea of top-down control mechanisms
that suppress automatic or reward-driven
responses (28). The early stages of recre-
ational drug taking are thought to be due
to personality characteristics that influ-
ence whether or not the individual will
try a rewarding substance. As mentioned
earlier, only a minority of these individu-
als become addicted (7). This fact implies
that the rewarding effect of drugs is not
the main factor in the development and
maintenance of addiction (29). These data
also suggest that other important factors
might drive the impetus to continue to use
or increase the quantity of drugs used by
those who become addicted. These factors
might include specific pre-existing subclin-
ical or clinical cognitive dysfunctions that
might have interfered with an individual’s
ability to resist drug-taking behaviors that
are known to contribute to adverse life
consequences.
The available evidence does support
the thesis that impulsivity is a vulner-
ability marker for substance abuse (11,
12). Several studies have demonstrated that
children of drug-using parents have ele-
vated impulsivity before drug exposure
and that impulsivity indices are strong
and reliable predictors of drug initia-
tion and drug-associated problems (11).
Importantly, during the interval of drug
taking while the addiction threshold might
be broached, taking of substantial amounts
of drugs might have produced additional
changes in the brains of susceptible indi-
viduals, with resulting further progression
of cognitive impairments that are well doc-
umented in several reports (11, 30–33).
Of importance to this thesis, cognitive
impairments have been shown to be greater
in drug-dependent individuals compared
with their siblings (12). The proposed
drug-induced pathological and/or func-
tional damage might be responsible for the
perseverative aspects of drug-taking behav-
iors that are somewhat akin to the perse-
veration observed in patients with severe
head traumas (34) or in patients with some
demented states (35). This similarity might
explain, in part, the perseverative taking of
drugs when they are no longer reinforc-
ing and/or when drug-taking behaviors are
accompanied by severe psychosocial and
medical consequences (23).
Interestingly, abnormalities have been
identified in frontal networks that sub-
sume poor self-regulation and impulse
control in cocaine dependency. Specifi-
cally, cocaine users were reported to show
stronger connectivity within the perigenual
anterior cingulate cortex (ACC) social pro-
cessing/“mentalizing” network (36). This
study is compatible with previous findings
of abnormal inhibitory control in cocaine
users (37, 38). Of etiological significance,
Kelly et al. (39) found increased but lower
resting connectivity between the ACC and
dorsolateral prefrontal cortex (DLPFC) in
children and adolescents, respectively. This
relationship was almost non-existent in
adults (39). These observations suggest that
the connectivity within these regions might
be “pruned” with brain maturation during
the aging process and that cocaine users
might suffer from a regression of these
maturational processes because of plas-
tic effects of the drug. This is important
because an efficient interaction of ACC and
DLPFC is needed for appropriate behav-
ioral control (40). Therefore, the cogni-
tive impulse control disorder observed in
addicted patients might be secondary to
drug-induced activation of developmental
genes that regulate connectivity between
various brain regions (41).
ATTENTION
Attention represents a number of intimate
mechanisms that facilitate the filtering,
selection, and processing of information
(42). In substance users, there is substantial
attentional bias toward substance-related
cues (43). Attentional bias exists to a greater
extent in people with highly compulsive
patterns of drug taking (43). Demonstra-
tions of attentional bias for substance-
related stimuli among experienced sub-
stance users are consistent with the view
that classical conditioning is involved
in their development because substance-
related cues are, by nature, associated with
the effects of substances (44). Other studies
have also documented drug-related deficits
in attentional tests in cocaine addicts
(32, 45, 46). Methamphetamine addicts
also showed deficits on measures of sus-
tained (47) and spatial (48) attention,
with these deficits having been linked to
methamphetamine-associated damage to
the ACC and insular cortices (47). Thus,
damage to these brain regions might play
an important role in causing dysfunctions
in attentional circuits that are critical to
learning and memory processes that are
important to remember specific therapeu-
tic interventions, thereby increasing the
rate of recidivism in addicted patients.
DECISION MAKING
Poor cognitive performance in areas of
risk-taking and decision making may influ-
ence the degree to which illicit drug users
engage in risky behaviors with consequent
negative health consequences. Deficits in
tests of decision making have been found
in patients who suffer from marijuana
(49, 50), cocaine (51), MDMA (52),
and methamphetamine (53, 54) addiction.
These deficits might be related to altered
connectivity of the right insula to the
dorsomedial PFC, inferior frontal gyrus,
and DLPFC in cocaine-dependent sub-
jects (55). Methamphetamine-dependent
individuals also showed disrupted risk-
related processing in the ACC and insula
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(54). Moreover, occasional stimulant users
also showed reward dysfunction during
reinforcement-based decision making and
greater activation in the ACC, inferior
frontal gyrus, and dorsal striatum com-
pared with control subjects (56). Therefore,
drug addiction might be associated with
altered functional connectivity in large-
scale neural networks that might serve to
distort awareness, salience detection, and
other functions that regulate various cog-
nitive processes including decision making,
with subsequent severe negative impacts on
activities of daily living (55).
CONCLUSION
In summary, drug addiction is marked
by mild, yet pervasive, cognitive disrup-
tions that may cause the negative progres-
sion of the clinical course, threaten sus-
tained abstinence (57), or increase recidi-
vism (58, 59) associated with addiction to
licit and illicit substances. Importantly, the
existence of cognitive deficits identified in
drug-dependent individuals suggests that
cognitive disturbances might be predispos-
ing risk factors for the development of
drug dependence (12). Repeated exposure
to various drugs of abuse might exacerbate
some of these subclinical abnormalities by
producing pathological changes in vari-
ous brain regions including the PFC (2).
Interestingly, recent neuroimaging stud-
ies have also documented cortical abnor-
malities in patients addicted to various
classes of illicit substances (60). These cor-
tical abnormalities, by causing disinhibi-
tion of various cortico-cortical, subcortico-
midbrain, or subcortico-cortical pathways,
might engender the formation of hyper-
connected subcortical loops that might
serve as substrates for the varied clin-
ical manifestations of addiction. Better
understanding of these neural connection-
induced cognitive deficits should help to
develop better pharmacological and behav-
ioral approaches for the treatment of sub-
stance use disorders.
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